Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer.
Kaufman
Jeffrey L
JL
D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017985:Dalteparin / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous / Q000191:economics; D020246:Venous Thrombosis / Q000517:prevention & control*; D014859:Warfarin / Q000191:economics / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D017985:Dalteparin